Bon Natural Life Limited (BON) Key Metrics
BON valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $9.3M
- Enterprise value
- $18.3M
- P/E (TTM)
- —
- Forward P/E
- 2.3
- PEG ratio
- —
- Price / sales
- 0.5
- Price / book
- 0.2
- EV / EBITDA
- 2.9
- Dividend yield
- —
- Beta
- −0.34
BON key metrics, FY2018–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsBON valuation Price multiples at each fiscal year-end price.
Price / sales−94.1%
0.3
FY2025 · hover or tap a bar for each year
FY2018FY2025
Price / book−96.5%
0.1
FY2025 · hover or tap a bar for each year
FY2018FY2025
Free cash flow yield−72.1 pts
−78.7%
FY2025 · hover or tap a bar for each year
FY2018FY2025
BON returns How much profit the business earns on the capital it uses.
Return on equity−4.9 pts
−3.9%
FY2025 · hover or tap a bar for each year
FY2018FY2025
Return on invested capital−4.3 pts
−2.2%
FY2025 · hover or tap a bar for each year
FY2018FY2025
Return on assets−3.5 pts
−2.7%
FY2025 · hover or tap a bar for each year
FY2018FY2025
Free cash flow margin+9.8 pts
−22.7%
FY2025 · hover or tap a bar for each year
FY2018FY2025
Asset turnover−42.3%
0.25
FY2025 · hover or tap a bar for each year
FY2018FY2025
BON per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−31.7%
$6.78
FY2025 · hover or tap a bar for each year
FY2018FY2025
Earnings per share
−$0.72
FY2025 · hover or tap a bar for each year
FY2018FY2025
Free cash flow per share
−$1.54
FY2025 · hover or tap a bar for each year
FY2018FY2025
Book value per share+14.3%
$20.89
FY2025 · hover or tap a bar for each year
FY2018FY2025
Shares outstanding+14.7%
2.8M
FY2025 · hover or tap a bar for each year
FY2018FY2025
BON financial health Debt, liquidity and how easily interest is covered.
Debt / equity+28.8%
0.21
FY2025 · hover or tap a bar for each year
FY2018FY2025
Net debt−$1.2M
$6.1M
FY2025 · hover or tap a bar for each year
FY2018FY2025
Current ratio−28.1%
1.74
FY2025 · hover or tap a bar for each year
FY2018FY2025
Interest coverage
-4.4
FY2025 · hover or tap a bar for each year
FY2018FY2025
Debt / assets+22.4%
0.14
FY2025 · hover or tap a bar for each year
FY2018FY2025
BON efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+103 days
228 days
FY2025 · hover or tap a bar for each year
FY2018FY2025
Days of inventory+137 days
257 days
FY2025 · hover or tap a bar for each year
FY2018FY2025
Days payables outstanding+84 days
137 days
FY2025 · hover or tap a bar for each year
FY2018FY2025
Cash conversion cycle+156 days
349 days
FY2025 · hover or tap a bar for each year
FY2018FY2025
Capex / revenue+23.4 pts
23.4%
FY2025 · hover or tap a bar for each year
FY2018FY2025
BON valuation history
Fiscal year-endToday8-year median
BON returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BON debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BON price vs earnings per share
Share price at year-endEPS (right axis)
BON key metrics
FY2018–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $5.4M | $117.1M | — | — | — | — | — | — |
| Enterprise value | $11.4M | $124.4M | — | — | — | — | — | — |
| P/E ratio | — | 294.2 | — | — | — | — | — | — |
| Price / sales | 0.3 | 4.9 | — | — | — | — | — | — |
| Price / book | 0.1 | 2.7 | — | — | — | — | — | — |
| Price / operating cash flow | 38.1 | — | — | — | — | — | — | — |
| EV / sales | 0.6 | 5.2 | — | — | — | — | — | — |
| EV / EBITDA | — | 54.1 | — | — | — | — | — | — |
| Earnings yield | −37.1% | 0.3% | — | — | — | — | — | — |
| Free cash flow yield | −78.7% | −6.6% | — | — | — | — | — | — |
| Share price at fiscal year-end | $1.95 | $48.75 | $100.75 | $540.75 | $2,117.50 | — | — | — |
| Per share | ||||||||
| Revenue per share | $6.78 | $9.92 | — | — | — | — | — | — |
| Earnings per share | −$0.72 | $0.17 | — | — | — | — | — | — |
| Operating cash flow per share | $0.05 | −$3.21 | — | — | — | — | — | — |
| Free cash flow per share | −$1.54 | −$3.22 | — | — | — | — | — | — |
| Cash per share | $2.27 | $0.03 | — | — | — | — | — | — |
| Book value per share | $20.89 | $18.27 | — | — | — | — | — | — |
| Tangible book value per share | $18.56 | $17.95 | — | — | — | — | — | — |
| Capex per share | $1.59 | $0.00 | — | — | — | — | — | — |
| Debt per share | $4.47 | $3.04 | — | — | — | — | — | — |
| Shares outstanding | 2.8M | 2.4M | — | — | — | — | — | — |
| Change in shares outstanding | +14.7% | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | −3.9% | 1.0% | 14.1% | 22.4% | 25.1% | 34.9% | 45.2% | 4.9% |
| Return on invested capital (ROIC) | −2.2% | 2.1% | 13.2% | 22.0% | 21.9% | 20.4% | 23.8% | 3.2% |
| Return on assets (ROA) | −2.7% | 0.7% | 11.0% | 16.9% | 14.9% | 13.5% | 14.2% | 1.3% |
| Return on tangible assets | −2.5% | 0.7% | 10.1% | 16.9% | 12.8% | 12.1% | 13.3% | 1.4% |
| Free cash flow margin | −22.7% | −32.4% | −2.4% | −16.5% | −2.7% | −9.3% | 0.2% | −13.1% |
| Income quality (OCF / net income) | — | −19.40 | −0.14 | −0.03 | 0.88 | 0.87 | 2.76 | 1.23 |
| Financial health | ||||||||
| Total debt | $12.3M | $7.3M | $4.2M | $5.4M | $3.2M | $5.7M | $6.1M | $6.5M |
| Cash & short-term investments | $6.3M | $80,466 | $111,299 | $840,861 | $3.6M | $53,106 | $293,771 | $820,856 |
| Net debt | $6.1M | $7.2M | $4.1M | $4.6M | −$397,747 | $5.7M | $5.8M | $5.7M |
| Debt / equity | 0.21 | 0.17 | 0.12 | 0.18 | 0.12 | 0.54 | 0.89 | 1.44 |
| Debt / assets | 0.14 | 0.12 | 0.09 | 0.15 | 0.09 | 0.23 | 0.31 | 0.39 |
| Net debt / EBITDA | — | 3.14 | 0.59 | 0.54 | −0.06 | 1.53 | 1.63 | 6.91 |
| Current ratio | 1.74 | 2.42 | 2.52 | 2.21 | 2.20 | 0.93 | 0.79 | 1.54 |
| Quick ratio | 1.01 | 2.32 | 1.54 | 1.95 | 1.44 | 0.84 | 0.55 | 0.46 |
| Interest coverage | -4.4 | 6.2 | 24.8 | 17.7 | 12.9 | 10.5 | 9.5 | 2.1 |
| Working capital | $19.5M | $23.3M | $14.6M | $8.1M | $9.0M | −$856,755 | −$2.3M | $4.7M |
| Invested capital | $63.6M | $51.1M | $39.6M | $34.1M | $25.6M | $16.2M | $12.6M | $10.3M |
| Tangible asset value | $51.6M | $43.6M | $35.0M | $29.7M | $26.1M | $10.9M | $7.1M | $4.4M |
| Net current asset value | $18.6M | $22.4M | $13.6M | $7.6M | $6.7M | −$3.3M | −$3.7M | $1.4M |
| Graham number | — | $8.25 | — | — | — | — | — | — |
| Graham net-net per share | −$0.96 | −$3.20 | — | — | — | — | — | — |
| Capital allocation | ||||||||
| Capex / revenue | 23.4% | 0.0% | 0.2% | 15.8% | 18.6% | 23.8% | 43.2% | 15.6% |
| Capex / operating cash flow | 3,097.9% | — | — | — | 117.3% | 163.9% | 99.6% | 615.0% |
| Capex / depreciation | 3.40 | 0.01 | 0.05 | 12.92 | 16.58 | 18.79 | 31.22 | 7.52 |
| Stock-based compensation / revenue | 7.5% | 5.5% | 0.4% | 0.6% | 0.2% | 0.0% | 0.2% | — |
| R&D / revenue | 4.0% | 6.8% | 1.0% | 1.4% | 1.0% | 1.1% | 3.2% | 5.2% |
| SG&A / revenue | 25.4% | 15.2% | 8.8% | 7.3% | 5.7% | 8.4% | 9.7% | 11.3% |
| Efficiency | ||||||||
| Days sales outstanding | 228.3 | 125.7 | 70.4 | 78.9 | 85.4 | 110.3 | 86.7 | 86.5 |
| Days of inventory on hand | 256.8 | 119.5 | 98.0 | 66.0 | 66.6 | 50.8 | 197.1 | 407.9 |
| Days payables outstanding | 136.6 | 52.7 | 14.3 | 5.3 | 16.6 | 63.2 | 97.6 | 118.2 |
| Cash conversion cycle (days) | 348.5 | 192.5 | 154.2 | 139.7 | 135.4 | 97.8 | 186.2 | 376.1 |
| Receivables turnover | 1.60 | 2.90 | 5.18 | 4.62 | 4.28 | 3.31 | 4.21 | 4.22 |
| Payables turnover | 2.67 | 6.93 | 25.54 | 68.86 | 22.03 | 5.77 | 3.74 | 3.09 |
| Inventory turnover | 1.42 | 3.05 | 3.72 | 5.53 | 5.48 | 7.19 | 1.85 | 0.89 |
| Asset turnover | 0.25 | 0.44 | 0.70 | 0.81 | 0.83 | 0.81 | 0.91 | 0.65 |
| Average receivables | $11.7M | $8.2M | $5.7M | $6.5M | $6.0M | $5.5M | $3.9M | $2.6M |
| Average payables | $5.5M | $2.4M | $809,761 | $297,485 | $834,507 | $2.3M | $3.0M | $2.7M |
| Average inventory | $10.4M | $5.5M | $5.6M | $3.7M | $3.4M | $1.8M | $6.0M | $9.4M |
| Intangibles / total assets | 7.5% | 1.3% | 2.1% | 1.0% | 1.1% | 0.6% | 0.7% | 0.9% |
Computed from BON's annual financial statements (latest annual report filed January 23, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BON valuation and financial ratios
Bon Natural Life earned a return on equity of −3.9% and a return on invested capital of −2.2% in fiscal 2025. It ended the year with $12.3 million of debt and $6.3 million in cash and short-term investments, net debt of $6.1 million.
See the BON income statement, the BON chart for price history, or the BON stock overview for the latest quote and news.
BON key metrics FAQ
What is Bon Natural Life's return on equity?
Bon Natural Life's return on equity (ROE) was −3.9% in fiscal 2025: net income of -$2.0 million on average shareholders' equity of $50.7 million.
What is Bon Natural Life's ROIC?
Bon Natural Life's return on invested capital was −2.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Bon Natural Life have?
Bon Natural Life had total debt of $12.3 million at the end of fiscal 2025, a debt-to-equity ratio of 0.21.
What is Bon Natural Life's free cash flow yield?
Bon Natural Life generated -$4.2 million of free cash flow in fiscal 2025, a free cash flow yield of −78.7% on its market value at year-end ($5.4 million).
What is Bon Natural Life's current ratio?
Bon Natural Life's current ratio was 1.74 at the end of fiscal 2025: current assets were 1.74 times current liabilities.